Pediatric antiphospholipid syndrome: Clinical and immunologic features of 121 patients in an international registry

Pediatrics

Volumn 122, Issue 5, 2008, Pages

  Avčin, Tadej ^a,q   Cimaz, Rolando ^a   Silverman, Earl D ^c   Cervera, Ricard ^d   Gattorno, Marco ^e,f   Garay, Stella ^g   Berkun, Yackov ^h,i   Sztajnbok, Flavio R ^j,k   Silva, Clovis A ^l   Campos, Lucia M ^l   Saad Magalhaes, Claudia ^m   Rigante, Donato ⁿ   Ravelli, Angelo ^e,f   Martini, Alberto ^e,f   Rozman, Blaz ^b   Meroni, Pier Luigi ^o,p  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF BARCELONA   (Spain)

^e G GASLINI INSTITUTE   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g Hospital de Ninos Sor Maria Ludovica   (Argentina)

^h SHEBA MEDICAL CENTER   (Israel)

ⁱ TEL AVIV UNIVERSITY   (Israel)

^j STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^k Universidade do Estado do Rio de Janeiro ^*  (Brazil)

^l UNIVERSITY OF SÃO PAULO   (Brazil)

^m SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

ⁿ CATHOLIC UNIVERSITY   (Italy)

^o UNIVERSITY OF MILAN   (Italy)

^p ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^q UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

more..

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Pediatrics

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; AGE DISTRIBUTION; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; AUTOIMMUNE DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL FEATURE; EUROPE; FEMALE; HEMATOLOGIC DISEASE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; RECURRENCE RISK; REGISTER; SEX RATIO; SKIN DISEASE; VEIN THROMBOSIS; AGE; CEREBROVASCULAR DISEASE; COMORBIDITY; GENETICS; IMMUNOLOGY; INFANT; ISCHEMIA; PRESCHOOL CHILD; THROMBOSIS;

ADOLESCENT; AGE FACTORS; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASES; CEREBROVASCULAR DISORDERS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; HUMANS; INFANT; ISCHEMIA; MALE; REGISTRIES; THROMBOSIS; VENOUS THROMBOSIS;

EID: 58149149373     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-1209     Document Type: Article

References (38)

1. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346(10):752-763
2. Giannakopoulos B, Passam, F, Rahgozar S, Krillis SA. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood. 2007;109(2):422-430
3. Cimaz R, Descloux E. Pediatric antiphospholipid syndrome. Rheum Dis Clin North Am. 2006;32(3):553-573
4. Avčin T, Silverman ED. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Lupus. 2007;16(8):627-633
5. Ravelli A, Martini A. Antiphospholipid syndrome in pediatrics. Rheum Dis Clin North Am. 2007;33(3):499-523
6. Avcin T, Cimaz R, Meroni PL. Do we need an international consensus statement on classification criteria for the antiphospholipid syndrome in the paediatric population? Lupus. 2001; 10(12):897-898
7. Berkun Y, Padeh S, Barash J, et al. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum. 2006;55(6):850-855
8. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost. 2006; 4(2):295-306
9. Boffa MC, Aurousseau MH, Lachassinne E, et al. European register of babies born to mothers with antiphospholipid syndrome. Lupus. 2004;13(9):713-717
10. Böber E, Kovanlikaya A, Büyükgebiz A. Primary antiphospholipid syndrome: an unusual cause of adrenal insufficiency. Horm Res. 2001;56(3-4):140-144
11. Uysal Z, Doǧu F, Kürekçi AE, et al. Recurrent arterial thrombosis in a child: primary antiphospholipid syndrome. Pediatr Hematol Oncol. 2002;19(1):59-66
12. Gattorno M, Falcini F, Ravelli A, et al. Outcome of primary antiphospholipid syndrome in childhood. Lupus. 2003;12(6):449-453
13. Kuzmanovska DB, Sahpazova EM, Grujovska SJ, Trajkovski Z. Renal infarction in a child with systemic lupus erythematosus. Pediatr Nephrol. 2004;19(6):685-687
14. Butani L. End-stage renal disease from glomerulonephritis associated with anti-phospholipid syndrome. Pediatr Nephrol. 2004;19(7):812-814
15. Emir M, Ozisik K, Cagli K, Bakuy V, Ozisik P, Sener E. Dural sinus thrombosis after cardiopulmonary bypass. Perfusion. 2004;19(2):133-135
16. Rodriguez V, Reed AM, Kuntz NL, Anderson PM, Smithson WA, Nichols WL. Antiphospholipid syndrome with catastrophic bleeding and recurrent ischemic strokes as initial presentation of systemic lupus erythematosus. J Pediatr Hematol Oncol. 2005;27(7):403-407
17. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019-1027
18. García-Carrasco M, Galarza C, Gómez-Ponce M, et al. Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients. Lupus. 2007;16(5):366-373
19. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12):836-843
20. Rajagopalan S, Somers EC, Brook RD, et al. Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. Blood. 2004;103(10):3677-3683
21. Meesters EW, Hansen H, Spronk HM, et al. The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus. Blood Coagul Fibrinolysis. 2007;18(1):21-28
22. Avčin T, Benseler SM, Tyrrell PN, Čučnik S, Silverman ED. A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus. Arthritis Rheum. 2008;59(2):206-213
23. Chapman J, Rand JH, Brey RL, et al. Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. Lupus. 2003;12(7): 514-517
24. Asherson RA, Cervera R. Unusual manifestations of the antiphospholipid syndrome. Clin Rev Allergy Immunol. 2003;25(1):61-78
25. Brouwer JP, Bijl M, Veeger NJGM, Kluin-Nelemans HC, van der Meer J. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood. 2004;104(1):143-148
26. Lawson SE, Butler D, Enayat MS, Williams MD. Congenital thrombophilia and thrombosis: a study in a single centre. Arch Dis Child. 1999;81(2):176-178
27. Revel-Vilk S, Chan A, Bauman M, Massicotte P. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. J Thromb Haemost. 2003;1(5):915-921
28. Barnes C, deVeber G. Prothrombotic abnormalities in childhood ischaemic stroke. Thromb Res. 2006;118(1):67-74
29. Levine SR, Brey RL, Tilley BC, et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA. 2004;291(5):576-584
30. Crowther MA, Ginsberg JS, Julian J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med. 2003;349(12):1133-1138
31. Finazzi G, Marchioli R, Brancaccio V, et al. A randomized clinical trial of high-intensity warfarin vs conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost. 2005;3(5):848 -853
32. Erkan D, Asherson RA, Espinosa G, et al. Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis. 2003;62(6):530-533
33. Ruiz-Irastorza G, Hunt BJ, Khamashta MA. A systematic review of secondary thromboprophylaxis in patients with antiphospho-lipid antibodies. Arthritis Rheum. 2007;57(8):1487-1495
34. Tarr T, Lakos G, Bhattoa HP, et al. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus. Lupus. 2007;16(5):324-328
35. Reber G, Schousboe I, Tincani A, et al. Inter-laboratory variability of anti-beta2-glycoprotein I measurement: a collaborative study in the frame of the European Forum on Antiphos- pholipid Antibodies Standardization Group. Thromb Haemost. 2002;88(1):66-73
36. Audrain MA, Colonna F, Morio F, Hamidou MA, Muller JY. Comparison of different kits in the detection of autoantibodies to cardiolipin and beta2glycoprotein 1. Rheumatology (Oxford). 2004;43(2):181-185
37. Pengo V, Biasiolo A, Bison E, Chantarangkul V, Tripodi A. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-glycoprotein I activity. Thromb Res. 2007;120(1):127-133
38. Diz-Küçükkaya R, Hacihanefioglu A, Yenerel M, et al. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood. 2001;98(6):1760-1764